| abstract |
Vaccine compositions for combating Poxviridae virus infection in living organisms, such as mammals (including humans), are known as TAP-1 and / or TAP to increase antigen processing capacity of infected cells and thereby increase their immunogenicity. Contains -2. Such compositions may be used alone or, preferably, as immunogenic-enhancing adjuvants with vaccines based on the FOX antigen, particularly in the treatment or prevention of smallpox virus infections. |